Balyasny Asset Management
CME icon

Balyasny Asset Management’s CME Group CME Stock Holding History

Balyasny Asset Management’s Portfolio CME Stock Details CME Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$137M Buy
464,624
+406,721
+702% +$121M 0.18% 113
2025
Q4 		$15.8M Buy
57,903
+12,647
+28% +$3.44M 0.02% 836
2025
Q3 		$12.2M Sell
45,256
-2,436
-5% -$663K 0.02% 950
2025
Q2 		$13.1M Sell
47,692
-385,265
-89% -$105M 0.02% 839
2025
Q1 		$115M Buy
432,957
+288,940
+201% +$71.3M 0.19% 103
2024
Q4 		$33.4M Sell
144,017
-1,141,943
-89% -$263M 0.05% 457
2024
Q3 		$284M Buy
1,285,960
+404,981
+46% +$83.8M 0.46% 25
2024
Q2 		$173M Buy
880,979
+392,598
+80% +$81.1M 0.3% 48
2024
Q1 		$105M Buy
488,381
+444,816
+1,021% +$93.4M 0.18% 109
2023
Q4 		$9.17M Sell
43,565
-88,845
-67% -$19M 0.02% 898
2023
Q3 		$26.5M Sell
132,410
-107,446
-45% -$21.4M 0.05% 479
2023
Q2 		$44.4M Buy
239,856
+166,704
+228% +$30.8M 0.1% 282
2023
Q1 		$14M Sell
73,152
-197,380
-73% -$35.7M 0.04% 649
2022
Q4 		$45.5M Buy
270,532
+217,785
+413% +$37.8M 0.12% 208
2022
Q3 		$9.34M Sell
52,747
-129,801
-71% -$25.7M 0.03% 719
2022
Q2 		$37.4M Buy
182,548
+24,882
+16% +$5.27M 0.12% 221
2022
Q1 		$37.5M Sell
157,666
-37,326
-19% -$8.77M 0.12% 220
2021
Q4 		$44.5M Sell
194,992
-124,806
-39% -$27.5M 0.15% 161
2021
Q3 		$61.8M Sell
319,798
-31,489
-9% -$6.38M 0.26% 74
2021
Q2 		$74.7M Buy
351,287
+111,056
+46% +$23.4M 0.35% 47
2021
Q1 		$49.1M Sell
240,231
-206,121
-46% -$40.6M 0.24% 91
2020
Q4 		$81.3M Buy
446,352
+284,616
+176% +$48.4M 0.45% 30
2020
Q3 		$27.1M Buy
161,736
+120,529
+292% +$20.3M 0.2% 138
2020
Q2 		$6.7M Hold
41,207
– – 0.06% 437
2020
Q1 		$7.13M Hold
41,207
– – 0.08% 319
2019
Q4 		$8.27M Sell
41,207
-84,504
-67% -$17.3M 0.05% 480
2019
Q3 		$26.6M Buy
125,711
+42,805
+52% +$8.94M 0.18% 170
2019
Q2 		$16.1M Sell
82,906
-66,376
-44% -$12.2M 0.1% 270
2019
Q1 		$24.6M Buy
149,282
+104,282
+232% +$18.4M 0.16% 184
2018
Q4 		$8.46M Sell
45,000
-209,475
-82% -$38.7M 0.06% 385
2018
Q3 		$43.3M Sell
254,475
-461,023
-64% -$77.6M 0.2% 132
2018
Q2 		$117M Buy
715,498
+628,565
+723% +$103M 0.53% 22
2018
Q1 		$14.1M Buy
86,933
+47,025
+118% +$7.49M 0.06% 423
2017
Q4 		$5.83M Sell
39,908
-1,258,017
-97% -$179M 0.02% 800
2017
Q3 		$176M Buy
1,297,925
+818,837
+171% +$103M 0.69% 16
2017
Q2 		$60M Sell
479,088
-147,424
-24% -$17.6M 0.25% 97
2017
Q1 		$74.4M Buy
626,512
+242,037
+63% +$29.1M 0.35% 58
2016
Q4 		$44.3M Buy
384,475
+181,806
+90% +$20.2M 0.24% 113
2016
Q3 		$21.2M Sell
202,669
-296,834
-59% -$31M 0.12% 235
2016
Q2 		$48.7M Buy
499,503
+446,515
+843% +$42.2M 0.32% 77
2016
Q1 		$5.09M Buy
52,988
+4,560
+9% +$415K 0.03% 536
2015
Q4 		$4.39M Sell
48,428
-48,950
-50% -$4.61M 0.03% 525
2015
Q3 		$9.03M Buy
97,378
+52,350
+116% +$4.98M 0.07% 369
2015
Q2 		$4.19M Hold
45,028
– – 0.03% 629
2015
Q1 		$4.26M Hold
45,028
– – 0.03% 500
2014
Q4 		$3.99M Sell
45,028
-45,000
-50% -$3.81M 0.04% 475
2014
Q3 		$7.2M Sell
90,028
-239,493
-73% -$18M 0.06% 374
2014
Q2 		$23.4M Buy
329,521
+284,493
+632% +$20M 0.26% 81
2014
Q1 		$3.33M Hold
45,028
– – 0.04% 422
2013
Q4 		$3.53M Buy
+45,028
New +$3.53M 0.05% 355
2013
Q3 		– Sell
-45,028
Closed -$3.42M – 583
2013
Q2 		$3.42M Buy
+45,028
New +$2.95M 0.06% 374

Other funds holding CME

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Balyasny Asset Management's CME Position: Q1 2026 in Review

Balyasny Asset Management increased its CME Group (CME) stake by 702% in Q1 2026, buying an estimated $121M and bringing the position to 464,624 shares worth $137M. The position accounts for 0.18% of the portfolio, ranked #113.

Balyasny Asset Management first reported a position in CME in Q2 2013 and has held it in 51 quarters since. The position peaked at $284M in Q3 2024. 1,790 funds tracked by Wall St. Rank hold CME as of Q1 2026.

  • Balyasny Asset Management held 464,624 shares of CME Group worth $137M as of Q1 2026.
  • Balyasny Asset Management bought 406,721 CME Group shares in Q1 2026, an estimated $121M.
  • CME Group made up 0.18% of Balyasny Asset Management's portfolio in Q1 2026, its #113 holding.
  • Balyasny Asset Management first reported a position in CME Group in Q2 2013 and has held it in 51 quarters since.
  • Balyasny Asset Management's CME Group position peaked at $284M in Q3 2024.
  • 1,790 funds tracked by Wall St. Rank held CME Group as of Q1 2026.

Based on Balyasny Asset Management's 13F filing for Q1 2026, filed 15 May 2026.